$366 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 52 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 20.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $32,483,000 | +7.5% | 444,000 | +14.1% | 8.87% | -9.1% |
| ACAD | ACADIA PHARMACEUTICALS INC | $25,982,000 | +29.6% | 486,000 | 0.0% | 7.10% | +9.6% | |
| VRTX | Buy | Vertex Pharmaceuticals Inc | $22,979,000 | +30.5% | 97,322 | +50.1% | 6.28% | +10.4% |
| BMRN | Biomarin Pharmaceutical Inc | $21,681,000 | +15.3% | 247,584 | 0.0% | 5.92% | -2.5% | |
| PTCT | Buy | PTC Therapuetics COM | $20,323,000 | +45.7% | 333,000 | +11.4% | 5.55% | +23.2% |
| GILD | Buy | Gilead Sciences Inc | $20,284,000 | -0.0% | 348,284 | +8.4% | 5.54% | -15.4% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $17,178,000 | +92.3% | 200,400 | +45.9% | 4.69% | +62.7% |
| AMGN | Buy | Amgen Inc | $16,548,000 | +48.1% | 72,000 | +63.6% | 4.52% | +25.2% |
| CCXI | Buy | CHEMOCENTRYX INC | $15,783,000 | +1121.6% | 255,600 | +983.1% | 4.31% | +933.8% |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $15,494,000 | +80.1% | 99,241 | +31.9% | 4.23% | +52.4% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $14,804,000 | +231.8% | 67,400 | +150.6% | 4.04% | +180.8% |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $13,816,000 | +353.0% | 113,541 | +224.4% | 3.77% | +283.0% |
| HALO | Halozyme Therapeutics Inc | $13,136,000 | +62.7% | 307,633 | 0.0% | 3.59% | +37.6% | |
| SGEN | New | SEAGEN INC | $11,471,000 | – | 65,500 | +100.0% | 3.13% | – |
| EXEL | Exelixis Inc | $10,568,000 | -17.8% | 526,534 | 0.0% | 2.89% | -30.4% | |
| XLRN | ACCELERON PHARMA INC | $9,063,000 | +13.6% | 71,000 | 0.0% | 2.48% | -3.9% | |
| BIIB | Sell | Biogen Inc | $8,020,000 | -35.1% | 32,800 | -24.8% | 2.19% | -45.1% |
| INCY | Incyte Corp | $6,776,000 | -3.2% | 78,000 | 0.0% | 1.85% | -18.1% | |
| REGN | Regeneron Pharmaceuticals | $5,549,000 | -13.7% | 11,500 | 0.0% | 1.52% | -27.0% | |
| SRPT | Sarepta Therapeutics Inc | $5,364,000 | +21.2% | 31,500 | 0.0% | 1.46% | +2.6% | |
| ALNY | Alnylam Pharmaceuticals Inc | $4,718,000 | -10.6% | 36,300 | 0.0% | 1.29% | -24.4% | |
| IONS | Buy | Ionis Pharmaceuticals Inc | $4,398,000 | +132.9% | 77,781 | +95.5% | 1.20% | +97.2% |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $3,368,000 | +83.2% | 22,000 | 0.0% | 0.92% | +55.1% | |
| KALV | Kalvista Pharmaceuticals Inc | $3,369,000 | +50.9% | 177,433 | 0.0% | 0.92% | +27.6% | |
| PTGX | PROTAGONIST THERAPEUTICS INC | $3,064,000 | +3.2% | 152,000 | 0.0% | 0.84% | -12.6% | |
| STRO | SUTRO BIOPHARMA INC | $3,014,000 | +115.7% | 139,331 | 0.0% | 0.82% | +82.5% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS INC | $2,853,000 | +227.2% | 50,000 | +194.1% | 0.78% | +176.2% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $2,693,000 | -43.6% | 58,000 | -60.0% | 0.74% | -52.3% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $2,527,000 | +296.7% | 79,456 | +220.4% | 0.69% | +235.0% |
| NBIX | Sell | Neurocrine Biosciences Inc | $2,299,000 | -89.2% | 24,000 | -89.2% | 0.63% | -90.9% |
| ASND | Ascendis Pharma ASsponsored adr | $2,298,000 | +8.1% | 13,800 | 0.0% | 0.63% | -8.5% | |
| ALLK | ALLAKOS INC | $2,195,000 | +71.6% | 15,700 | 0.0% | 0.60% | +45.0% | |
| FOLD | Amicus Therapeutics Inc | $2,185,000 | +63.5% | 94,600 | 0.0% | 0.60% | +38.5% | |
| BPMC | Blueprint Medicines Corp | $2,187,000 | +21.0% | 19,500 | 0.0% | 0.60% | +2.2% | |
| MRSN | MERSANA THERAPEUTICS INC | $1,911,000 | +42.6% | 72,000 | 0.0% | 0.52% | +20.6% | |
| ORIC | New | ORIC PHARMACEUTICALS INC | $1,789,000 | – | 53,000 | +100.0% | 0.49% | – |
| New | Arena Pharmaceuticals Inc | $1,614,000 | – | 21,000 | +100.0% | 0.44% | – | |
| EXAS | Exact Sciences Corp | $1,418,000 | +30.0% | 10,700 | 0.0% | 0.39% | +9.9% | |
| GWPH | GW Pharmaceuticals Plcads | $1,176,000 | +18.4% | 10,200 | 0.0% | 0.32% | 0.0% | |
| AXSM | New | AXSOME THERAPEUTICS INC | $1,140,000 | – | 14,000 | +100.0% | 0.31% | – |
| NKTR | NEKTAR THERAPEUTICS | $1,139,000 | +2.6% | 67,000 | 0.0% | 0.31% | -13.1% | |
| INSM | INSMED INC | $1,119,000 | +3.6% | 33,600 | 0.0% | 0.31% | -12.3% | |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $1,085,000 | -36.0% | 78,500 | -31.7% | 0.30% | -45.9% |
| QURE | UNIQURE NV | $994,000 | -1.9% | 27,500 | 0.0% | 0.27% | -17.1% | |
| GBT | Global Blood Therapeutics | $944,000 | -21.5% | 21,800 | 0.0% | 0.26% | -33.5% | |
| AGIO | Agios Pharmaceuticals Inc | $932,000 | +23.9% | 21,500 | 0.0% | 0.26% | +4.9% | |
| FGEN | FibroGen Inc | $731,000 | -9.8% | 19,700 | 0.0% | 0.20% | -23.4% | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $545,000 | – | 20,000 | +100.0% | 0.15% | – |
| BLUE | Bluebird Bio Inc | $476,000 | -19.7% | 11,000 | 0.0% | 0.13% | -31.9% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $247,000 | -30.0% | 9,500 | 0.0% | 0.07% | -41.2% | |
| ANAB | ANAPTYSBIO INC | $215,000 | +45.3% | 10,000 | 0.0% | 0.06% | +22.9% | |
| ZEAL | ZEALAND PHARMA A Ssponsored adr | $203,000 | -3.3% | 5,653 | 0.0% | 0.06% | -19.1% | |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -25,000 | -100.0% | -0.18% | – |
| ARNA | Exit | Arena Pharmaceuticals Inc | $0 | – | -16,500 | -100.0% | -0.40% | – |
| IMUX | Exit | IMMUNIC INC | $0 | – | -123,000 | -100.0% | -0.74% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -49,700 | -100.0% | -1.36% | – |
| MYOK | Exit | Myokardia INC | $0 | – | -65,859 | -100.0% | -2.90% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -65,500 | -100.0% | -4.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.